TCT 2011 News


 TitlePublished DateAuthor(s)
TWENTE: Zotarolimus DES Noninferior to Everolimus DES at 1 YearNovember 29, 2011L.A. McKeown
EVOLVE: Bioabsorbable EES Noninferior to Permanent Polymer VersionNovember 11, 2011Kim Dalton
Friday, November 11th, 2011November 11, 2011TCT Daily Staff
Two New SES Show Improvement Over First-Generation StentsNovember 11, 2011Yael L. Maxwell
ADAPT-DES: Risk of Early Stent Thrombosis in DES Predicted by Platelet InhibitionNovember 10, 2011TCT Daily Staff
BRIDGE: Cangrelor Provides Effective Maintenance of Platelet Inhibition Without Major BleedingNovember 10, 2011TCT Daily Staff
Complications After TAVR: Manageable, But Important to ConsiderNovember 10, 2011TCT Daily Staff
Embolic Protection Devices for TAVR Show PromiseNovember 10, 2011TCT Daily Staff
MUSTELA: Thrombectomy Use Not Associated with Smaller Infarcts at 1 YearNovember 10, 2011TCT Daily Staff
PARIS: Early DAPT Nonadherence, A Small Problem with Big ConsequencesNovember 10, 2011TCT Daily Staff
PARTNER A: Transfemoral TAVR Improved QOL, Costs vs. SurgeryNovember 10, 2011TCT Daily Staff
PARTNER Cohort B: TAVR Remains Superior to Standard Therapy at 2 YearsNovember 10, 2011TCT Daily Staff
RAPID GENE: Validation of Point-of-Care Genetic TestingNovember 10, 2011TCT Daily Staff
Recovery in Japan Ongoing, But Help Still NeededNovember 10, 2011TCT Daily Staff
RIFLE STEACS: Radial Approach Safer Than Femoral in STEMINovember 10, 2011TCT Daily Staff
STACCATO: Transapical TAVR Inferior to Surgery for Operable Elderly PatientsNovember 10, 2011TCT Daily Staff
Thursday, November 10th, 2011November 10, 2011TCT Daily Staff
APICE-OCT: EES, ZES Yield Low Rates of Uncovered Struts in ACSNovember 09, 2011TCT Daily Staff
Bioabsorbable Polymers, Scaffolds Offer Permanent AdvantagesNovember 09, 2011TCT Daily Staff
Caution Urged in Widespread Adoption of TAVRNovember 09, 2011TCT Daily Staff
Coronary Heart Disease Mortality Down, But Prevention Efforts Still NeededNovember 09, 2011TCT Daily Staff
DEB Promising in Critical Limb Ischemia, Femoropopliteal Arterial DiseaseNovember 09, 2011TCT Daily Staff
EES Compared Favorably with SES In Two Pivotal TrialsNovember 09, 2011TCT Daily Staff
Long-term Outcomes Improved with Biodegradable Biolimus-Eluting Stent vs. Permanent Polymer SESNovember 09, 2011TCT Daily Staff
Low Event Rates with EES Sustained at 2 YearsNovember 09, 2011TCT Daily Staff
Mitral, Aortic Regurgitation Increase Mortality After Transcatheter Valve ReplacementNovember 09, 2011TCT Daily Staff
Mock Jury Votes on DAPT Duration: 12 Months Remains Best Option for Most PatientsNovember 09, 2011TCT Daily Staff
Next-Generation Devices Address Complications of TAVRNovember 09, 2011TCT Daily Staff
Ongoing Trials Explore Potential Benefits of Transradial PCINovember 09, 2011TCT Daily Staff
Polymer-free DES Shown Effective in Multiple TrialsNovember 09, 2011TCT Daily Staff
123